The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B

Oligomers are commonly observed intermediates at the initial stages of amyloid fibril formation. They are toxic to neurons and cause decrease in neural transmission and long-term potentiation. We describe an in vitro study of the initial steps in amyloid fibril formation by human stefin B, which proved to be a good model system. Due to relative stability of the initial oligomers of stefin B, electrospray ionization mass spectrometry (ESI MS) could be applied in addition to size exclusion chromatography (SEC). These two techniques enabled us to separate and detect distinguished oligomers from the monomers: dimers, trimers, tetramers, up to decamers. The amyloid fibril formation process was followed at different pH and temperatures, including such conditions where the process was slow enough to detect the initial oligomeric species at the very beginning of the lag phase and those at the end of the lag phase. Taking into account the results of the lower-order oligomers transformations early in the process, we were able to propose an improved model for the stefin B fibril formation.

• Publication year

  2013

• Venue

  International Journal of Molecular Sciences

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3390/ijms140918362PMID 24013380PMCID 3794784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Alzheimer's amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization.

  2013cited by this paper
• Influence of partial unfolding and aggregation of human stefin B (cystatin B) EPM1 mutants G50E and Q71P on selective cleavages by cathepsins B and S

  2013cited by this paper
• Advances in ion mobility spectrometry–mass spectrometry reveal key insights into amyloid assembly☆

  2013cited by this paper
• Pore formation by human stefin B in its native and oligomeric states and the consequent amyloid induced toxicity

  2012cited by this paper
• Mass Spectrometry Based Approaches to Study Biomolecular Dynamics: Equilibrium Intermediates

  2012cited by this paper
• Mapping local structural perturbations in the native state of stefin B (cystatin B) under amyloid forming conditions

  2012cited by this paper
• Development of the structural core and of conformational heterogeneity during the conversion of oligomers of the mouse prion protein to worm-like amyloid fibrils.

  2012cited by this paper
• Structure and dynamics of oligomeric intermediates in β2-microglobulin self-assembly.

  2011cited by this paper
• Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Aβ1-40 peptide oligomers.

  2011cited by this paper
• Role of small oligomers on the amyloidogenic aggregation free-energy landscape.

  2010cited by this paper
• 1 Supplementary data for : Ion Mobility Separation coupled with MS detects two structural states of Alzheimer ’ s disease Aβ 1-40 peptide oligomers

  2010cited by this paper
• The mechanism of amyloid‐fibril formation by stefin B: Temperature and protein concentration dependence of the rates

  2009cited by this paper
• Interaction between Oligomers of Stefin B and Amyloid-β in Vitro and in Cells*

  2009cited by this paper
• Organization of nucleobase-functionalized beta-peptides investigated by soft electrospray ionization mass spectrometry.

  2009cited by this paper
• Characterization of intrinsically disordered proteins with electrospray ionization mass spectrometry: Conformational heterogeneity of α‐synuclein

  2009cited by this paper
• Cystatin B Deficiency Sensitizes Neurons to Oxidative Stress in Progressive Myoclonus Epilepsy, EPM1

  2009cited by this paper
• MEROPS: the peptidase database

  2009cited by this paper
• Structure–neurotoxicity relationships of amyloid β-protein oligomers

  2009cited by this paper
• Essential role of Pro 74 in stefin B amyloid‐fibril formation: Dual action of cyclophilin A on the process

  2009cited by this paper
• Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B

  2008cited by this paper
• Similar toxicity of the oligomeric molten globule state and the prefibrillar oligomers

  2008cited by this paper
• Stepwise evolution of protein native structure with electrospray into the gas phase, 10−12 to 102 s

  2008cited by this paper
• Interaction with model membranes and pore formation by human stefin B – studying the native and prefibrillar states

  2008cited by this paper
• Cystatins: biochemical and structural properties, and medical relevance.

  2008cited by this paper
• Exclusion of the native alpha-helix from the amyloid fibrils of a mixed alpha/beta protein.

  2008cited by this paper
• Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo.

  2008cited by this paper
• Monitoring Copopulated Conformational States During Protein Folding Events Using Electrospray Ionization-Ion Mobility Spectrometry-Mass Spectrometry

  2007cited by this paper
• Native protein MS and ion mobility large flying proteins with ESI.

  2007cited by this paper
• Essential role of proline isomerization in stefin B tetramer formation.

  2007cited by this paper
• Amyloid fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology

  2007cited by this paper
• Protein folding mechanisms studied by time-resolved electrospray mass spectrometry.

  2006cited by this paper
• Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry.

  2006cited by this paper
• Interaction of human stefin B in the prefibrillar oligomeric form with membranes

  2005cited by this paper
• In vitro study of stability and amyloid‐fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1

  2005cited by this paper
• Mass spectrometry in biophysics : conformation and dynamics of biomolecules

  2005cited by this paper
• Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged

  2005cited by this paper
• Protein aggregation as a possible cause for pathology in a subset of familial Unverricht-Lundborg disease.

  2005cited by this paper
• MEROPS: the peptidase database

  2004cited by this paper
• Differences in aggregation properties of three site‐specific mutants of recombinant human stefin B

  2004cited by this paper
• Different propensity to form amyloid fibrils by two homologous proteins—Human stefins A and B: Searching for an explanation

  2004cited by this paper
• Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.

  2004cited by this paper
• Alzheimer's disease Abeta peptide fragment 10-30 forms a spectrum of metastable oligomers with marked preference for N to N and C to C monomer termini proximity.

  2004cited by this paper
• FOCUS :N ONCOVALENT INTERACTIONS Comparative ESI-MS Study of 2.2 MDa Native Hemocyanins from Deep-Sea and Shore Crabs: From Protein Oligomeric State to Biotope

  2003cited by this paper
• Comparative ESI-MS study of approximately 2.2 MDa native hemocyanins from deep-sea and shore crabs: from protein oligomeric state to biotope.

  2003cited by this paper
• Origin of the conformation dependence of protein charge-state distributions in electrospray ionization mass spectrometry.

  2003cited by this paper
• Evidence for non-isostructural replacement of Zn(2+) with Cd(2+) in the beta-domain of brain-specific metallothionein-3.

  2002cited by this paper
• Unverricht-Lundborg disease with cystatin B gene abnormalities.

  2002cited by this paper
• Electrospray ionization mass spectrometry analysis revealed a ∼310 kDa noncovalent hexamer of HPr kinase/phosphatase from Bacillus subtilis

  2002cited by this paper
• Human stefin B readily forms amyloid fibrils in vitro.

  2002cited by this paper
• Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators.

  2002cited by this paper
• Amyloid Fibril Formation by Human Stefin B in vitro: Immunogold Labelling and Comparison to Stefin A

  2002cited by this paper
• Quadrupole time-of-flight mass spectrometry of the native hemocyanin of the deep-sea crab Bythograea thermydron.

  2002cited by this paper
• Evidence for non‐isostructural replacement of Zn2+ with Cd2+ in the β‐domain of brain‐specific metallothionein‐3

  2002cited by this paper
• Screening transthyretin amyloid fibril inhibitors: characterization of novel multiprotein, multiligand complexes by mass spectrometry.

  2002cited by this paper
• Three‐dimensional domain swapping in the folded and molten‐globule states of cystatins, an amyloid‐forming structural superfamily

  2001cited by this paper
• cystatins: protein inhibitors of cysteine proteinases

  2001cited by this paper
• Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1).

  2001cited by this paper
• The effect of the source pressure on the abundance of ions of noncovalent protein assemblies in an electrospray ionization orthogonal time-of-flight instrument.

  2001cited by this paper
• Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry.

  2000cited by this paper
• Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.

  2000cited by this paper
• Accessing the global minimum conformation of stefin A dimer by annealing under partially denaturing conditions.

  1999cited by this paper
• Differences in the effects of TFE on the folding pathways of human stefins A and B

  1999cited by this paper
• On the mechanism of human stefin B folding: II. Folding from GuHCl unfolded, TFE denatured, acid denatured, and acid intermediate states

  1998cited by this paper
• Equilibrium unfolding of proteins monitored by electrospray ionization mass spectrometry: distinguishing two-state from multi-state transitions.

  1998cited by this paper
• Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry.

  1998cited by this paper
• On the mechanism of human stefin B folding: I. Comparison to homologous stefin A. Influence of pH and trifluoroethanol on the fast and slow folding phases

  1998cited by this paper
• Novel cystatin B mutation and diagnostic PCR assay in an Unverricht-Lundborg progressive myoclonus epilepsy patient.

  1997cited by this paper
• Studying noncovalent protein complexes by electrospray ionization mass spectrometry.

  1997cited by this paper
• Genetics of epilepsy : Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)

  1996cited by this paper
• Compactness of the molten globule in comparison to unfolded states as observed by size-exclusion chromatography.

  1994cited by this paper
• Calorimetric measurements of thermal denaturation of stefins A and B. Comparison to predicted thermodynamics of stefin-B unfolding.

  1992cited by this paper
• Intermediates in denaturation of a small globular protein, recombinant human stefin B.

  1992cited by this paper
• The refined 2.4 A X‐ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction.

  1990cited by this paper
• Cloning a synthetic gene for human stefin B and its expression in E. coli

  1988cited by this paper
• Protein inhibitors of cysteine proteinases. I. Isolation and characterization of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes.

  1983cited by this paper

• Dissecting Hidden Liraglutide Oligomerization Pathways via Direct Mass Technology, Electron-Capture Dissociation, and Molecular Dynamics

  2025cites this paper
• Unveiling the Hidden: Dissecting Liraglutide Oligomerization Dual Pathways via Direct Mass Technology, Electron-Capture Dissociation, and Molecular Dynamics

  2025cites this paper
• The Inhibition of Serum Amyloid A Protein Aggregation by a Five-Residue Peptidomimetic: Structural and Morphological Insights

  2024cites this paper
• Amyloid Fibrils of Stefin B Show Anisotropic Properties

  2023cites this paper
• Identification of the Most Impactful Asparagine Residues for γS-Crystallin Aggregation by Deamidation.

  2023cites this paper
• Synergy of the Inhibitory Action of Polyphenols Plus Vitamin C on Amyloid Fibril Formation: Case Study of Human Stefin B

  2021cites this paper
• Crystal structure and physicochemical characterization of a phytocystatin from Humulus lupulus: Insights into its domain-swapped dimer.

  2020cites this paper
• Antioxidants From the Class of Polyphenols, NAC and Vitamin C Act Differently on Amyloid Fibril Formation by Two Human Cystatins: Stefin B and Cystatin C.

  2020cites this paper
• Prolines Affect the Nucleation Phase of Amyloid Fibrillation Reaction; Mutational Analysis of Human Stefin B

  2019cites this paper
• Possible Mechanisms by which Stefin B could Regulate Proteostasis and Oxidative Stress

  2019cites this paper
• Inhibition of Protein Aggregation by Several Antioxidants

  2018cites this paper
• Proline Residues as Switches in Conformational Changes Leading to Amyloid Fibril Formation

  2017cites this paper
• Putative alternative functions of human stefin B (cystatin B): binding to amyloid‐beta, membranes, and copper

  2017cites this paper
• Protein Domain-Swapping Can Be a Consequence of Functional Residues.

  2016cites this paper
• Assembly of Stefin B into Polymorphic Oligomers Probed by Discrete Molecular Dynamics.

  2015cites this paper
• Structure and Function of Stefin B Oligomers – Important Role in Amyloidogenesis

  2014cites this paper
• On Possible Function and Toxicity of Multiple Oligomeric/Conformational States of a Globular Protein – Human Stefin B

  2014cites this paper